Data gathered: October 17
Alternative Data for Dexcom
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 268 | Sign up | Sign up | Sign up |
| Sentiment | 74 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,419,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 804 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 11,552 | Sign up | Sign up | Sign up |
| Facebook Followers | 201,543 | Sign up | Sign up | Sign up |
| Instagram Followers | 181,887 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 43 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 9,953 | Sign up | Sign up | Sign up |
| Twitter Followers | 8,840 | Sign up | Sign up | Sign up |
| Twitter Mentions | 30 | Sign up | Sign up | Sign up |
| X Mentions | 43 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 48,400 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 69 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,056 | Sign up | Sign up | Sign up |
About Dexcom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
| Price | $66.33 |
| Target Price | Sign up |
| Volume | 3,960,000 |
| Market Cap | $26B |
| Year Range | $59.83 - $90.75 |
| Dividend Yield | 0% |
| PE Ratio | 46.71 |
| Analyst Rating | 87% buy |
| Earnings Date | October 30 '25 |
| Industry | Medical Devices |
In the news
 |
Here’s Why Artisan Mid Cap Fund Exited Dexcom (DXCM)October 16 - Yahoo Entertainment |
 |
The Bull Case For DexCom (DXCM) Could Change Following Cautious Full-Year Outlook Amid Sector SelloffOctober 14 - Yahoo |
|
DexCom (DXCM): Valuation in Focus After Q2 Revenue Beat and Cautious Outlook on Sector TensionsOctober 14 - Yahoo |
|
Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring SegmentOctober 13 - Yahoo |
|
William Blair Maintains Bullish Stance on DexCom (DXCM) StockOctober 7 - Yahoo |
 |
DexCom, Inc. $DXCM Position Increased by Ascent Group LLCOctober 7 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 1.16B | 468M | 689M | 180M | 309M | 0.480 |
| Q1 '25 | 1.04B | 447M | 589M | 105M | 219M | 0.320 |
| Q4 '24 | 1.11B | 458M | 656M | 152M | 274M | 0.380 |
| Q3 '24 | 994M | 400M | 594M | 135M | 237M | 0.450 |
| Q2 '24 | 1B | 378M | 627M | 144M | 245M | 0.430 |
Insider Transactions View All
| Malady Kyle filed to sell 22,667 shares at $80.9. September 9 '25 |
| Stern Sadie filed to sell 105,223 shares at $80. September 8 '25 |
| Sylvain Jereme M filed to sell 118,657 shares at $74.2. September 4 '25 |
| FOLETTA MARK G filed to sell 51,121 shares at $81.5. August 18 '25 |
| Brown Michael Jon filed to sell 94,102 shares at $80.3. August 18 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$97.78 0% | 55 |
 |
Edwards LifesciencesEW |
$72.65 0% | 60 |
 |
Intuitive SurgicalISRG |
$434.62 0% | 70 |
 |
MedtronicMDT |
$95.04 0% | 59 |
 |
StrykerSYK |
$369.25 0% | 72 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul |
Oct 13, 25 | Buy | $1K - $15K |
| Michael McCaul |
Jul 9, 25 | Sell | $15K - $50K |
| Michael McCaul |
Jul 9, 25 | Buy | $15K - $50K |
Read more about Dexcom (DXCM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Dexcom?
The Market Cap of Dexcom is $26B.
What is Dexcom's PE Ratio?
As of today, Dexcom's PE (Price to Earnings) ratio is 46.71.
When does Dexcom report earnings?
Dexcom will report its next earnings on October 30 '25.
What is the current stock price of Dexcom?
Currently, the price of one share of Dexcom stock is $66.33.
How can I analyze the DXCM stock price chart for investment decisions?
The DXCM stock price chart above provides a comprehensive visual representation of Dexcom's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Dexcom shares. Our platform offers an up-to-date DXCM stock price chart, along with technical data analysis and alternative data insights.
Does DXCM offer dividends to its shareholders?
As of our latest update, Dexcom (DXCM) does not offer dividends to its shareholders. Investors interested in Dexcom should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Dexcom?
Some of the similar stocks of Dexcom are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.
